Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Nuformix (NFX) Share Price

Price 0.125p on 09-10-2026 at 17:45:09
Change 0.00p 0%
Buy 0.13p
Sell 0.12p
Last Trade: Unknown 924,874.00 at 0.125p
Day's Volume: 14,769,762
Last Close: 0.125p
Open: 0.125p
ISIN: GB00BYW79Y38
Day's Range 0.125p - 0.125p
52wk Range: 0.125p - 0.53p
Market Capitalisation: £3.26m
VWAP: 0.124336p
Shares in Issue: 2.61b

Nuformix (NFX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 924,874 0.125p Uncrossing Trade
16:35:22 - 09-Oct-26
Sell* 5,000,000 0.1244p Ordinary
16:28:34 - 09-Oct-26
Sell* 5,941 0.12p Ordinary
15:44:31 - 09-Oct-26
Sell* 3,193,874 0.1244p Ordinary
12:54:12 - 09-Oct-26
Sell* 500,000 0.1244p Ordinary
12:02:59 - 09-Oct-26
Sell* 245,413 0.1211p Ordinary
11:57:24 - 09-Oct-26
Sell* 2,000,000 0.1247p Ordinary
10:57:22 - 09-Oct-26
Buy* 15,426 0.129p Ordinary
10:35:08 - 09-Oct-26
Unknown* 100,000 0.125p Ordinary
09:42:18 - 09-Oct-26
Unknown* 2,000,000 0.125p Ordinary
08:50:53 - 09-Oct-26
See more Nuformix trades

Nuformix (NFX) Share Price History

Time period:
to
Date Open High Low Close Volume
9th Oct 2026 (Fri) 0.125 0.125 0.125 0.125 14,769,762
8th Oct 2026 (Thu) 0.135 0.135 0.125 0.125 53,167,752
7th Oct 2026 (Wed) 0.135 0.135 0.135 0.135 8,649,922
6th Oct 2026 (Tue) 0.135 0.135 0.135 0.135 6,247,821
5th Oct 2026 (Mon) 0.135 0.135 0.135 0.135 13,895,849
2nd Oct 2026 (Fri) 0.135 0.1355 0.1355 0.1355 6,332,276
1st Oct 2026 (Thu) 0.145 0.14 0.14 0.14 12,038,657
30th Sep 2026 (Wed) 0.145 0.145 0.145 0.145 8,284,490
29th Sep 2026 (Tue) 0.15 0.145 0.139 0.145 12,627,079
28th Sep 2026 (Mon) 0.135 0.15 0.135 0.15 72,855,027
25th Sep 2026 (Fri) 0.135 0.14 0.135 0.135 1,386,531
24th Sep 2026 (Thu) 0.135 0.141 0.129 0.129 5,712,521
23rd Sep 2026 (Wed) 0.129 0.135 0.129 0.135 10,299,280
22nd Sep 2026 (Tue) 0.135 0.141 0.141 0.141 5,565,615
21st Sep 2026 (Mon) 0.155 0.1495 0.1495 0.1495 82,786,467
18th Sep 2026 (Fri) 0.155 0.155 0.155 0.155 11,093,874
17th Sep 2026 (Thu) 0.155 0.155 0.155 0.155 17,575,570
16th Sep 2026 (Wed) 0.155 0.155 0.155 0.155 6,802,501
15th Sep 2026 (Tue) 0.155 0.155 0.155 0.155 3,776,298
14th Sep 2026 (Mon) 0.165 0.155 0.15 0.155 8,141,293
11th Sep 2026 (Fri) 0.165 0.165 0.165 0.165 2,369,158
10th Sep 2026 (Thu) 0.165 0.166 0.165 0.165 6,747,361
See more Nuformix price history

Nuformix (NFX) Regulatory News

Date Source Headline
25th Aug 2026 7:00 am RNS Appointment of Chairman
19th Aug 2026 7:00 am RNS NXP002 Development Update
28th May 2026 7:00 am RNS Half Year Report
31st Mar 2026 7:00 am RNS Total Voting Rights
11th Mar 2026 7:00 am RNS £1.0 million Placing
10th Mar 2026 7:00 am RNS Confirmation of US ODD for NXP002 in IPF
3rd Mar 2026 10:05 am RNS Result of AGM
5th Feb 2026 12:00 pm RNS Posting of Annual Report and Notice of AGM
27th Jan 2026 7:00 am RNS Annual Results for period ended 30 September 2025
28th Nov 2025 3:22 pm RNS Total Voting Rights
See more Nuformix regulatory news

Nuformix (NFX) Share News

WINNERS & LOSERS: Kelso buys into Likewise; Litigation Capital plunges

8th Oct 2026 11:01

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More

WINNERS & LOSERS: Petro Matad sinks on PetroChina blow; Midwich up

22nd Sep 2026 10:46

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

WINNERS & LOSERS: Tribal to sell assets; Brave Bison ups System1 tilt

14th Sep 2026 11:05

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

IN BRIEF: Nuformix hires ex-Zeus Capital joint CEO Metcalfe as chair

25th Aug 2026 12:17

Nuformix PLC - London-based pharmaceutical development company focused on fibrosis and oncology via drug repurposing - Hires Tim Metcalfe to be non-executive chair, starting September 1, Tuesday next week. Metcalfe is a corporate financier who among other City roles was joint CEO of Zeus Capital Ltd. At Nuformix, he replaces Julian Gilbert, who is stepping down for "personal reasons". Gilbert has been on the board since 2020 and chair since 2022. Read More

Nuformix shares up after positive preclinical studies against fibrosis

19th Aug 2026 16:52

(Alliance News) - Nuformix PLC shares spiked on Wednesday after the company shared positive results from its first preclinical studies on inhaled treatments for fibrosis. Read More

See more Nuformix news
FTSE 100 Latest
Value10,552.05
Change110.45

Login to your account

Forgot Password?

Not Registered